“A 68-year-old man with stage 4 metastatic pancreatic ductal adenocarcinoma refused conventional treatment and opted for intravenous vitamin C in doses of 75 to 125 g two to three times a week….He survived nearly four years, during which time he received more than 450 vitamin C infusions and had objective evidence of disease regression.” From a Townsend Letter research article, “Treatment of Pancreatic Cancer with Intravenous Vitamin C.”

For more health conditions check out the Evidence-based Research Articles database.